Finance

Beta
Lists
CARL:NASDAQ
Carlsmed Inc
$11.76
+4.63%
(+0.52) 1D
$11.79
+0.26% (+0.030)
After hours
Closed: Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CARL...
Open
$11.26
High
$11.84
Low
$11.20
Mkt. cap
319.69M
Avg. vol.
191.71K
Volume
311.67K
52-wk high
$17.19
52-wk low
$8.50
EPS
-$1.31
Shares outstanding
27.18M
No. of employees
127
Open
$11.26
High
$11.84
Low
$11.20
Mkt. cap
319.69M
Avg. vol.
191.71K
Volume
311.67K
52-wk high
$17.19
52-wk low
$8.50
EPS
-$1.31
Shares outstanding
27.18M
No. of employees
127
News stories
From sources across the web
About Carlsmed Inc
CEO-
Employees127
Founded2018
Headquarters-
SectorMedical device
Websitecarlsmed.com
Analyst ratings
Based on 4 analysts giving stock ratings to CARL in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CARL in the last 3 months.
Highest
Current $11.76
$23.00 (+95.58%)
Average
$18.75 (+59.44%)
Lowest
$16.00 (+36.05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Zimmerman
BTIG
Buy
Maintained
$23.00
+95.6%
06/22/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$18.00
+53.1%
06/03/2026
Richard Newitter
Truist Financial
Buy
Reiterated
$18.00
+53.1%
05/06/2026
David Roman
Goldman Sachs
Buy
Maintained
$16.00
+36.1%
05/05/2026
Travis Steed
Bank of America Securities
Buy
Reiterated
$17.00
+44.6%
02/26/2026
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.26 / -$0.39
+32.49%beat
Revenue / Est. (USD)
16.12M / 14.97M
+7.66%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
12.08M
13.07M
15.16M
16.12M
Cost of goods sold
3.21M
3.15M
3.56M
3.69M
Cost of revenue
3.21M
3.15M
3.56M
3.69M
Research and development expenses
4.16M
4.44M
5.26M
5.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.21M
14.52M
15.66M
16.52M
Operating expense
15.37M
18.96M
20.93M
21.70M
Total operating expenses
18.58M
22.11M
24.48M
25.39M
Operating income
-6.50M
-9.04M
-9.32M
-9.28M
Other non operating income
-237.00K
-65.00K
7.00K
-
EBT including unusual items
-6.77M
-8.53M
-8.61M
-8.70M
EBT excluding unusual items
-6.77M
-8.53M
-8.61M
-8.70M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.77M
-8.53M
-8.61M
-8.70M
Net profit margin
-56.00%
-65.21%
-56.80%
-53.96%
Earnings per share
-1.37
-0.37
-0.29
-0.26
Interest and investment income
336.00K
954.00K
1.03M
891.00K
Interest expense
-363.00K
-380.00K
-330.00K
-311.00K
Net interest expenses
-27.00K
574.00K
698.00K
580.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.44M
-8.95M
-9.22M
-9.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CARL
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer